Drug delivery systems for differential release in combination therapy
Authors:
- 11 January 2011
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Delivery
- Vol. 8 (2) , 171-190
Abstract
Introduction: Combination therapy with multiple therapeutic agents has wide applicability in medical and surgical treatment, especially in the treatment of cancer. Thus, new drug delivery systems that can differentially release two or more drugs are desired. Utilizing new techniques to engineer the established drug delivery systems and synthesizing new materials and designing carriers with new structures are feasible ways to fabricate proper multi-agent delivery systems, which are critical to meet requirements in the clinic and improve therapeutic efficacy. Areas covered: This paper aims to give an overview about the multi-agent delivery systems developed in the last decade for differential release in combination therapy. Multi-agent delivery systems from nanoscale to bulk scale, such as liposomes, micelles, polymer conjugates, nano/micorparticles and hydrogels, developed over the last 10 years, have been collected and summarized. The characteristics of different delivery systems are described and discuss...Keywords
This publication has 98 references indexed in Scilit:
- Nanoparticle therapeutics: an emerging treatment modality for cancerNature Reviews Drug Discovery, 2008
- Hydrogels in drug delivery: Progress and challengesPolymer, 2008
- Pegylated liposomal doxorubicin in the treatment of cancers of the breast and ovaryExpert Opinion on Pharmacotherapy, 2006
- Recent advances with liposomes as pharmaceutical carriersNature Reviews Drug Discovery, 2005
- In Vitro Cytotoxicity of Stealth Liposomes Co-encapsulating Doxorubicin and Verapamil on Doxorubicin-Resistant Tumor CellsBiological and Pharmaceutical Bulletin, 2005
- Recent advances on chitosan-based micro- and nanoparticles in drug deliveryJournal of Controlled Release, 2004
- Drug Delivery Systems: Entering the MainstreamScience, 2004
- Phase IV Study of Liposomal Daunorubicin (DaunoXome) in AIDS-Related Kaposi SarcomaAmerican Journal of Clinical Oncology, 2002
- Block copolymer micelles for delivery of gene and related compoundsAdvanced Drug Delivery Reviews, 2002
- Liposomal Anticancer Drugs as Agents to be used in Combination with other Anticancer Agents: Studies on a Liposomal Formulation with two Encapsulated DrugsJournal of Liposome Research, 1999